Previous product
Back to products
Xalkori (crizotinib)
CHF4,927.62
Next product
Cosela (trilaciclib)
CHF2,581.69
Fotivda (tivozanib)
CHF4,511.72
Fotivda (tivozanib) is a prescription medicine used to treat adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies.
Reviews
There are no reviews yet.